# A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

> **NCT05279846** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Moberg Pharma AB** · enrollment: 350 (estimated)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** MOB015B
- **DRUG:** Vehicle (Placebo Comparator)

## Key facts

- **NCT ID:** NCT05279846
- **Lead sponsor:** Moberg Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-09
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2024-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05279846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05279846, "A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05279846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*